Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

BACKGROUND. Highly HLA–sensitized kidney transplant candidates are difficult to desensitize, which reduces their chances of receiving a transplant. METHODS. We administered tocilizumab as a monotherapy (8 mg/kg once a mo) to 14 highly sensitized kidney transplant candidates. Highest mean fluorescenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Daligault, Mélanie, Bardy, Béatrice, Noble, Johan, Bourdin, Anne, Masson, Dominique, Naciri Bennani, Hamza, Bugnazet, Mathilde, Malvezzi, Paolo, Rostaing, Lionel, Jouve, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078280/
https://www.ncbi.nlm.nih.gov/pubmed/33912657
http://dx.doi.org/10.1097/TXD.0000000000001139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078280/
https://www.ncbi.nlm.nih.gov/pubmed/33912657
http://dx.doi.org/10.1097/TXD.0000000000001139

Ejemplares similares